153 related articles for article (PubMed ID: 3214041)
1. [High-risk acute lymphoblastic leukemia].
Martínez Rubio A; Doñoro Mazario M; Sánchez Luna M; Muro Brussi M; Lamamie de Cleirac P; García-Monge Santidrián S
An Esp Pediatr; 1988 Oct; 29 Suppl 34():66-8. PubMed ID: 3214041
[No Abstract] [Full Text] [Related]
2. [High-risk acute lymphoblastic leukemia. Results of a diagnostic-therapeutic protocol].
Castell V; Verdaguer A; Ferris J; Piqueras AI; Fernández JM
An Esp Pediatr; 1988 Oct; 29 Suppl 34():89-91. PubMed ID: 3214045
[No Abstract] [Full Text] [Related]
3. Biology and treatment of acute lymphoblastic leukemia.
Pieters R; Carroll WL
Pediatr Clin North Am; 2008 Feb; 55(1):1-20, ix. PubMed ID: 18242313
[TBL] [Abstract][Full Text] [Related]
4. Transplantation in childhood very high risk acute lymphoblastic leukemia in first complete remission: where are we now?
Balduzzi A; Conter V; Uderzo C; Valsecchi MG
J Clin Oncol; 2007 Jun; 25(18):2625-6; author reply 2627-8. PubMed ID: 17577046
[No Abstract] [Full Text] [Related]
5. [Our experience in the treatment of acute lymphoblastic leukemias (ALL) having different risk levels with the BFM-83 therapeutic protocol].
Bernacer M; Aracil J; Contra T; Gil C; López J; López-Ibor B; Martín N; Melero C; Valverde F; Vecilla C
An Esp Pediatr; 1988 Oct; 29 Suppl 34():68-72. PubMed ID: 3214042
[No Abstract] [Full Text] [Related]
6. [Cytosine arabinoside and VM-26 in induction treatment, failures and recurrences of childhood acute lymphoblastic leukemias].
Navajas Gutiérrez A; Bezanilla Regato JL; Moya Calderón E; Piñán MA
An Esp Pediatr; 1988 Oct; 29 Suppl 34():91-3. PubMed ID: 3214046
[No Abstract] [Full Text] [Related]
7. [Changes in body height and weight of children with long-term remission of acute lymphoblastic leukemia].
Traczewska M; Ochocka M; Palczewska I
Pediatr Pol; 1988 Nov; 63(11):739-46. PubMed ID: 3253661
[No Abstract] [Full Text] [Related]
8. Effectiveness of intrathecal rituximab in patients with acute lymphoblastic leukaemia relapsed to the CNS and resistant to conventional therapy.
Jaime-Pérez JC; Rodríguez-Romo LN; González-Llano O; Chapa-Rodríguez A; Gómez-Almaguer D
Br J Haematol; 2009 Mar; 144(5):794-5. PubMed ID: 19036096
[No Abstract] [Full Text] [Related]
9. Treatment of high-risk acute lymphoblastic leukemia with protocols PETHEMA LAL 7/78 and LAL 17/84.
Ortega JJ; Javier G; Olivé T
An Esp Pediatr; 1988 Oct; 29 Suppl 34():72-83. PubMed ID: 3214043
[No Abstract] [Full Text] [Related]
10. Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remission.
Fouillard L; Labopin M; Gratwohl A; Gluckman E; Frassoni F; Beelen DW; Willemze R; Montserrat E; Blaise D; Atienza AI; Sierra J; Santos M; Gorin NC; Rocha V;
Haematologica; 2008 Jun; 93(6):834-41. PubMed ID: 18469352
[TBL] [Abstract][Full Text] [Related]
11. [Use of monoclonal antibodies in acute lymphoblastic leukemia in children. II. Clinical picture and prognosis in specific immunological subgroups].
Kołecki P; Radwańska U
Pediatr Pol; 1988 Nov; 63(11):698-702. PubMed ID: 3253656
[No Abstract] [Full Text] [Related]
12. [Early deaths and intensification of the treatment of acute lymphoblastic leukemia in children].
Rytlewska M; Kubiczek K; Tretowska D
Pol Tyg Lek; 1988 Jul; 43(28):910-2. PubMed ID: 3247261
[No Abstract] [Full Text] [Related]
13. [Results of the treatment for infant acute lymphoblastic leukemia treated in the program Dana-Faber Cancer Institute. Report of Polish Pediatric Study Group for Leukemia and Lymphoma].
Sońta-Jakimczyk D; Olejnik I; Armata J; Bogusławska-Jaworska J; Kołecki P; Kowalczyk J; Rokicka-Milewska R; Chybicka A; Derwich K; Drabko K; Hicke-Roberts A; Kubiczek K; Steczowicz M
Wiad Lek; 1998; 51 Suppl 4():52-8. PubMed ID: 10731944
[TBL] [Abstract][Full Text] [Related]
14. Osteonecrosis in children with acute lymphoblastic leukemia: a 10-year study from northern Greece.
Tragiannidis A; Athanassiadou F; Papageorgiou T; Petsatodis G; Sidi V; Koliouskas D
Pediatr Blood Cancer; 2007 Oct; 49(5):764. PubMed ID: 17216599
[No Abstract] [Full Text] [Related]
15. Treatment of pediatric acute lymphoblastic leukemia.
Tucci F; Aricò M
Haematologica; 2008 Aug; 93(8):1124-8. PubMed ID: 18669975
[No Abstract] [Full Text] [Related]
16. [Intensification of chemotherapy in maintenance therapy and in periodic reinduction of remission in high-risk childhood ALL].
Indiano JM; Echaniz I; Humayor J; Delgado A
An Esp Pediatr; 1988 Oct; 29 Suppl 34():94-8. PubMed ID: 3214047
[No Abstract] [Full Text] [Related]
17. Prognostic factors for leukemic induction failure in children with acute lymphoblastic leukemia and outcome after salvage therapy: the FRALLE 93 study.
Oudot C; Auclerc MF; Levy V; Porcher R; Piguet C; Perel Y; Gandemer V; Debre M; Vermylen C; Pautard B; Berger C; Schmitt C; Leblanc T; Cayuela JM; Socie G; Michel G; Leverger G; Baruchel A
J Clin Oncol; 2008 Mar; 26(9):1496-503. PubMed ID: 18349402
[TBL] [Abstract][Full Text] [Related]
18. [Studies of fibronectin levels in recurrences of proliferative diseases of the hematopoietic system in children].
Matysiak M; Hryniewicz HJ; Ochocka M
Pediatr Pol; 1988 Nov; 63(11):723-7. PubMed ID: 3253659
[No Abstract] [Full Text] [Related]
19. Intensified chemotherapy for childhood lymphoblastic leukemia: modifications and results of induction treatment in St. Jude Study XI.
Rivera GK; Kalwinsky DK; Mirro J; Pui CH; Abromowitch M; Ochs J; Furman W; Santana V; Look AT; Dow LW
An Esp Pediatr; 1988 Oct; 29 Suppl 34():83-8. PubMed ID: 3214044
[TBL] [Abstract][Full Text] [Related]
20. Eligibility for allogeneic transplantation in very high risk childhood acute lymphoblastic leukemia: the impact of the waiting time.
Balduzzi A; De Lorenzo P; Schrauder A; Conter V; Uderzo C; Peters C; Klingebiel T; Stary J; Felice MS; Magyarosy E; Schrappe M; Dini G; Gadner H; Valsecchi MG
Haematologica; 2008 Jun; 93(6):925-9. PubMed ID: 18413892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
